Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | Shah Aarti S.Director | Open-market sale · 10b5-1 plan | SELL | $36K 202 sh | Mar 20, 2026 |
| 25 | McMillen Charles ThomasDirector | Open-market sale | SELL | $44K 55.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 25 | Finn Mark StevenDirector | Open-market purchase | BUY | $14K 500 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 25 | Finn Mark StevenDirector | Open-market purchase | BUY | $14K 500 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 24 | Stanton CarlDirector | Derivative conversion | C | $2.28M 2.53M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Focus Impact Sponsor, LLC10% Owner | Derivative conversion | C | $3.21M 3.56M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Caljouw Lynne JEVP, Chief HR Officer | Open-market sale | SELL | $86K 2,480 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 24 | Popeck Thomas CCEO, Henry Schein Products | Open-market sale | SELL | $99K 1,355 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 24 | Stanton CarlDirector | Derivative conversion | C | $2.28M 2.53M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Focus Impact Partners, LLC10% Owner | Derivative conversion | C | $2.28M 2.53M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Focus Impact Partners, LLC10% Owner | Derivative conversion | C | $2.28M 2.53M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Jahnel DarrinDirector | Other acquisition or disposition | J | $15K 462 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 24 | Terreri Donald JosephController, Chief Acct Officer | Tax withholding | F | $54K 12.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 23 | Middleton Piers DayerEVP & Chief Operating Officer | Grant or award | A | $500K 6,643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 23 | Madan Gopal AjayChief Financial Officer | Open-market sale | SELL | $479K 51.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 23 | Moore MichaelPresident | Open-market sale | SELL | $371K 40.2K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 23 | Lane Kenneth ToddDirector, President & CEO | Tax withholding | F | $516K 19.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 23 | Moore MichaelPresident | Open-market sale | SELL | $570K 65.0K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 22 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $297K 6,161 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Statham JamiSVP, General Counsel | Grant or award | A | — 80.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Hill Donna K.VP, Human Resources | Grant or award | A | — 39.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Neagle MatthewChief Operating Officer | Grant or award | A | — 826.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 21 | Benvenuti Raynard D.Director | Grant or award | A | — 51.8K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | de Figueiredo Joao MDirector | Grant or award | A | — 17 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Terreri Donald JosephController, Chief Acct Officer | Grant or award | A | — 25.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Van Tuyl ChristopherChief Legal Officer | Open-market sale | SELL | $72K 2,877 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Toth PeterEVP, Chief Sustain & Dev Off | Open-market sale · 10b5-1 plan | SELL | $324K 3,000 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $1,818 380 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2,913 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | Mar 20, 2026 traded Mar 12, 2026 |
| 20 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $5,671 1,183 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $88K 34.4K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $21K 4,486 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $2,907 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $3,705 774 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $3,274 684 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 19 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $187K 3,795 sh | Mar 20, 2026 traded Mar 20, 2026 |